FTSE All-Share
|
5 211,88
|
-29,02
|
-0,55 %
|
Analysen zu FTSE All-Share-Werten
| 05.12.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 05.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.12.23 | Glencore Equal Weight | Barclays Capital | |
| 04.12.23 | Diageo Underperform | RBC Capital Markets | |
| 04.12.23 | Diageo Sell | Deutsche Bank AG | |
| 04.12.23 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 01.12.23 | National Grid Outperform | RBC Capital Markets | |
| 01.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.12.23 | BP Overweight | Barclays Capital | |
| 01.12.23 | GSK Buy | Deutsche Bank AG | |
| 01.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 01.12.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 01.12.23 | BAT Overweight | Barclays Capital | |
| 01.12.23 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 30.11.23 | BP Outperform | RBC Capital Markets | |
| 29.11.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 29.11.23 | BP Hold | Jefferies & Company Inc. | |
| 29.11.23 | Shell Buy | Jefferies & Company Inc. | |
| 29.11.23 | Diageo Neutral | JP Morgan Chase & Co. | |
| 29.11.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 29.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 28.11.23 | Glencore Outperform | RBC Capital Markets | |
| 28.11.23 | GSK Buy | Deutsche Bank AG | |
| 27.11.23 | Unilever Overweight | Barclays Capital | |
| 27.11.23 | HSBC Holdings Neutral | UBS AG | |
| 27.11.23 | BP Outperform | RBC Capital Markets | |
| 27.11.23 | Rio Tinto Neutral | UBS AG | |
| 27.11.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.11.23 | Vodafone Group Buy | UBS AG | |
| 23.11.23 | BAT Sector Perform | RBC Capital Markets | |
| 23.11.23 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 22.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 22.11.23 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 21.11.23 | National Grid Overweight | JP Morgan Chase & Co. | |
| 20.11.23 | AstraZeneca Overweight | Barclays Capital | |
| 20.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 17.11.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 17.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.11.23 | GSK Hold | Jefferies & Company Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| Diageo | 8 |
| National Grid | 4 |
| AstraZeneca | 4 |
| GSK | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.